109 related articles for article (PubMed ID: 11054523)
1. Computed tomography/magnetic resonance based volume changes of the primary tumour in patients with prostate cancer with or without androgen deprivation.
Lilleby W; Fosså SD; Knutsen BH; Abildgaard A; Skovlund E; Lien HH
Radiother Oncol; 2000 Nov; 57(2):195-200. PubMed ID: 11054523
[TBL] [Abstract][Full Text] [Related]
2. Intermittent versus continuous total androgen blockade in the treatment of patients with advanced hormone-naive prostate cancer: results of a prospective randomized multicenter trial.
de Leval J; Boca P; Yousef E; Nicolas H; Jeukenne M; Seidel L; Bouffioux C; Coppens L; Bonnet P; Andrianne R; Wlatregny D
Clin Prostate Cancer; 2002 Dec; 1(3):163-71. PubMed ID: 15046691
[TBL] [Abstract][Full Text] [Related]
3. Changes in treatment volume of hormonally treated and untreated cancerous prostate and its impact on rectal dose.
Lilleby W; Dale E; Olsen DR; Gude U; Fosså SD
Acta Oncol; 2003; 42(1):10-4. PubMed ID: 12665325
[TBL] [Abstract][Full Text] [Related]
4. [Intermittent androgen deprivation treatment of prostate cancer restarted at low level of serum prostate specific antigen: a pilot study].
Maekawa S; Maegawa M; Ushida H; Inoue K; Kaneko Y; Ohmori K; Nishimura K
Hinyokika Kiyo; 2001 Aug; 47(8):553-5. PubMed ID: 11579594
[TBL] [Abstract][Full Text] [Related]
5. Advanced prostate cancer treated with intermittent or continuous androgen deprivation in the randomised FinnProstate Study VII: quality of life and adverse effects.
Salonen AJ; Taari K; Ala-Opas M; Viitanen J; Lundstedt S; Tammela TL;
Eur Urol; 2013 Jan; 63(1):111-20. PubMed ID: 22857983
[TBL] [Abstract][Full Text] [Related]
6. Comparison of intermittent and continuous androgen deprivation and quality of life between patients with locally advanced and patients with metastatic prostate cancer: a post hoc analysis of the randomized FinnProstate Study VII.
Salonen AJ; Taari K; Ala-Opas M; Sankila A; Viitanen J; Lundstedt S; Tammela TL;
Scand J Urol; 2014 Dec; 48(6):513-22. PubMed ID: 24679247
[TBL] [Abstract][Full Text] [Related]
7. Intermittent androgen deprivation: update of cycling characteristics in patients without clinically apparent metastatic prostate cancer.
Grossfeld GD; Chaudhary UB; Reese DM; Carroll PR; Small EJ
Urology; 2001 Aug; 58(2):240-5. PubMed ID: 11489710
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant androgen deprivation and prostate gland shrinkage during conformal radiotherapy.
Sanguineti G; Marcenaro M; Franzone P; Foppiano F; Vitale V
Radiother Oncol; 2003 Feb; 66(2):151-7. PubMed ID: 12648786
[TBL] [Abstract][Full Text] [Related]
9. The long-term results with delayed-combined androgen blockade therapy in local or locally advanced prostate cancer.
Soga N; Hori Y; Ogura Y; Hayashi N; Sugimura Y
Jpn J Clin Oncol; 2012 Jun; 42(6):534-40. PubMed ID: 22438406
[TBL] [Abstract][Full Text] [Related]
10. Intermittent androgen deprivation in prostate cancer patients: factors predictive of prolonged time off therapy.
Strum SB; Scholz MC; McDermed JE
Oncologist; 2000; 5(1):45-52. PubMed ID: 10706649
[TBL] [Abstract][Full Text] [Related]
11. Intermittent androgen deprivation therapy may prolong the duration of androgen dependence of well-differentiated prostate cancer.
Kaneko Y; Maekawa S; Arakaki R; Okada Y; Terada N; Nishimura K
Hinyokika Kiyo; 2006 Apr; 52(4):259-64. PubMed ID: 16686352
[TBL] [Abstract][Full Text] [Related]
12. Effects of androgen deprivation on prostatic morphology and vascular permeability evaluated with mr imaging.
Padhani AR; MacVicar AD; Gapinski CJ; Dearnaley DP; Parker GJ; Suckling J; Leach MO; Husband JE
Radiology; 2001 Feb; 218(2):365-74. PubMed ID: 11161148
[TBL] [Abstract][Full Text] [Related]
13. [Hormonal therapy for prostate cancer: methods and prognosis].
Huang BX; Su HC; Cao WL; Sun FK
Zhonghua Nan Ke Xue; 2013 Sep; 19(9):815-9. PubMed ID: 24386861
[TBL] [Abstract][Full Text] [Related]
14. Degarelix as an intermittent androgen deprivation therapy for one or more treatment cycles in patients with prostate cancer.
Boccon-Gibod L; Albers P; Morote J; van Poppel H; de la Rosette J; Villers A; Malmberg A; Neijber A; Montorsi F
Eur Urol; 2014 Oct; 66(4):655-63. PubMed ID: 24954791
[TBL] [Abstract][Full Text] [Related]
15. High-dose radiotherapy with short-term or long-term androgen deprivation in localised prostate cancer (DART01/05 GICOR): a randomised, controlled, phase 3 trial.
Zapatero A; Guerrero A; Maldonado X; Alvarez A; Gonzalez San Segundo C; Cabeza Rodríguez MA; Macias V; Pedro Olive A; Casas F; Boladeras A; de Vidales CM; Vazquez de la Torre ML; Villà S; Perez de la Haza A; Calvo FA
Lancet Oncol; 2015 Mar; 16(3):320-7. PubMed ID: 25702876
[TBL] [Abstract][Full Text] [Related]
16. Intermittent androgen deprivation for patients with recurrent/metastatic prostate cancer.
Youssef E; Tekyi-Mensah S; Hart K; Bolton S; Forman J
Am J Clin Oncol; 2003 Oct; 26(5):e119-23. PubMed ID: 14528085
[TBL] [Abstract][Full Text] [Related]
17. Preliminary results of a prospective randomized study comparing radical prostatectomy versus radical prostatectomy associated with neoadjuvant hormonal combination therapy in T2-3 N0 M0 prostatic carcinoma. The European Study Group on Neoadjuvant Treatment of Prostate Cancer.
Witjes WP; Schulman CC; Debruyne FM
Urology; 1997 Mar; 49(3A Suppl):65-9. PubMed ID: 9123739
[TBL] [Abstract][Full Text] [Related]
18. Potential benefits of intermittent androgen suppression therapy in the treatment of prostate cancer: a systematic review of the literature.
Abrahamsson PA
Eur Urol; 2010 Jan; 57(1):49-59. PubMed ID: 19683858
[TBL] [Abstract][Full Text] [Related]
19. Population-based estimate of the use of intermittent androgen deprivation therapy in prostate cancer patients in Catalonia, Spain.
Cordero JA; Sancho G; Bonfill X
Pharmacoepidemiol Drug Saf; 2019 Jun; 28(6):796-803. PubMed ID: 30839139
[TBL] [Abstract][Full Text] [Related]
20. Intermittent androgen deprivation for clinically localized prostate cancer: initial experience.
Grossfeld GD; Small EJ; Carroll PR
Urology; 1998 Jan; 51(1):137-44. PubMed ID: 9457309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
